

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.10017551 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.08555499 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.06375795 |
| 4 | daunorubicin metabolic process (GO:0044597) | 4.81204098 |
| 5 | polyketide metabolic process (GO:0030638) | 4.81204098 |
| 6 | doxorubicin metabolic process (GO:0044598) | 4.81204098 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.71622927 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.71622927 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.71622927 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.71622927 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.71622927 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.71622927 |
| 13 | T-helper 1 type immune response (GO:0042088) | 4.57052708 |
| 14 | neutrophil activation (GO:0042119) | 4.50018823 |
| 15 | response to peptidoglycan (GO:0032494) | 4.48204732 |
| 16 | granulocyte activation (GO:0036230) | 4.48008022 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.36604487 |
| 18 | regulation of activation of Janus kinase activity (GO:0010533) | 3.97350364 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.96324438 |
| 20 | * detection of molecule of bacterial origin (GO:0032490) | 3.95715186 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.95078535 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 3.94962426 |
| 23 | positive regulation of mast cell activation (GO:0033005) | 3.88173499 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.87139601 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87139601 |
| 26 | respiratory burst (GO:0045730) | 3.86499426 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.84624637 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 3.84624637 |
| 29 | regulation of RIG-I signaling pathway (GO:0039535) | 3.80020495 |
| 30 | eosinophil chemotaxis (GO:0048245) | 3.79643856 |
| 31 | superoxide anion generation (GO:0042554) | 3.73942362 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 3.70180168 |
| 33 | cellular extravasation (GO:0045123) | 3.70025141 |
| 34 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.69741155 |
| 35 | negative regulation of interleukin-17 production (GO:0032700) | 3.68645011 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.67289322 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.67289322 |
| 38 | cellular response to zinc ion (GO:0071294) | 3.66071718 |
| 39 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.63554616 |
| 40 | cellular response to interferon-beta (GO:0035458) | 3.60607942 |
| 41 | response to type I interferon (GO:0034340) | 3.60583124 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.58544291 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.47964794 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.47872218 |
| 45 | monocyte chemotaxis (GO:0002548) | 3.47587400 |
| 46 | macrophage activation (GO:0042116) | 3.45290860 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.44212354 |
| 48 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44057421 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43912458 |
| 50 | * detection of external biotic stimulus (GO:0098581) | 3.38670453 |
| 51 | response to interferon-beta (GO:0035456) | 3.37614453 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.36727851 |
| 53 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.34738624 |
| 54 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.33847913 |
| 55 | myeloid dendritic cell differentiation (GO:0043011) | 3.33174658 |
| 56 | microglial cell activation (GO:0001774) | 3.32911539 |
| 57 | eosinophil migration (GO:0072677) | 3.32373580 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.32036782 |
| 59 | defense response to protozoan (GO:0042832) | 3.30097439 |
| 60 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29961426 |
| 61 | natural killer cell mediated immunity (GO:0002228) | 3.29961426 |
| 62 | positive regulation of leukocyte degranulation (GO:0043302) | 3.28154937 |
| 63 | detection of other organism (GO:0098543) | 3.25595613 |
| 64 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25316093 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.25268616 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24316676 |
| 67 | response to host immune response (GO:0052572) | 3.24316676 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23902144 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.22938923 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21544755 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.20296782 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19906025 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19786265 |
| 74 | glycosphingolipid catabolic process (GO:0046479) | 3.19283901 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 3.18694743 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18350986 |
| 77 | negative regulation of viral genome replication (GO:0045071) | 3.18258404 |
| 78 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.16688093 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.16679373 |
| 80 | reactive oxygen species biosynthetic process (GO:1903409) | 3.15298654 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.15267753 |
| 82 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.15251743 |
| 83 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.14497545 |
| 84 | amino sugar catabolic process (GO:0046348) | 3.12607006 |
| 85 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.12166802 |
| 86 | regulation of interleukin-17 production (GO:0032660) | 3.11886335 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11352158 |
| 88 | * detection of biotic stimulus (GO:0009595) | 3.11337377 |
| 89 | positive regulation of interferon-beta production (GO:0032728) | 3.11286384 |
| 90 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11109833 |
| 91 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.10658737 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 3.10643425 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07441456 |
| 94 | B cell mediated immunity (GO:0019724) | 3.06202912 |
| 95 | regulation of mononuclear cell migration (GO:0071675) | 3.04014230 |
| 96 | oligosaccharide catabolic process (GO:0009313) | 3.03714413 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 3.03524736 |
| 98 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.03177077 |
| 99 | myeloid leukocyte activation (GO:0002274) | 3.00332516 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.99494937 |
| 101 | cellular response to exogenous dsRNA (GO:0071360) | 2.99304813 |
| 102 | leukocyte aggregation (GO:0070486) | 2.98211510 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97568553 |
| 104 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.97303623 |
| 105 | response to interferon-alpha (GO:0035455) | 2.97167038 |
| 106 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.94767102 |
| 107 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.94724095 |
| 108 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.93978340 |
| 109 | response to protozoan (GO:0001562) | 2.93918795 |
| 110 | germinal center formation (GO:0002467) | 2.93808796 |
| 111 | positive regulation of lymphocyte migration (GO:2000403) | 2.92934252 |
| 112 | positive regulation of macrophage differentiation (GO:0045651) | 2.92060271 |
| 113 | detection of bacterium (GO:0016045) | 2.90213695 |
| 114 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.90024066 |
| 115 | response to interferon-gamma (GO:0034341) | 2.89008875 |
| 116 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88359425 |
| 117 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.88307459 |
| 118 | endosome to pigment granule transport (GO:0043485) | 2.87718977 |
| 119 | endosome to melanosome transport (GO:0035646) | 2.87718977 |
| 120 | positive regulation of interleukin-17 production (GO:0032740) | 2.87695882 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87075936 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85953498 |
| 123 | glycolipid catabolic process (GO:0019377) | 2.85472283 |
| 124 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.84432565 |
| 125 | regulation of antigen processing and presentation (GO:0002577) | 2.83992956 |
| 126 | regulation of hypersensitivity (GO:0002883) | 2.83958069 |
| 127 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83844065 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83439487 |
| 129 | response to host (GO:0075136) | 2.83439487 |
| 130 | response to host defenses (GO:0052200) | 2.83439487 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83142694 |
| 132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83011382 |
| 133 | regulation of type 2 immune response (GO:0002828) | 2.81611207 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.81207820 |
| 135 | response to muramyl dipeptide (GO:0032495) | 2.81157819 |
| 136 | regulation of chemokine biosynthetic process (GO:0045073) | 2.80715186 |
| 137 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.80624548 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80008361 |
| 139 | regulation of mast cell degranulation (GO:0043304) | 2.79591230 |
| 140 | lymphocyte chemotaxis (GO:0048247) | 2.78422123 |
| 141 | positive regulation of interleukin-10 production (GO:0032733) | 2.78374888 |
| 142 | regulation of fever generation (GO:0031620) | 2.77764697 |
| 143 | positive regulation of interleukin-6 production (GO:0032755) | 2.77594467 |
| 144 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76599987 |
| 145 | neutrophil chemotaxis (GO:0030593) | 2.76453657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.26448515 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.71120610 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.70535536 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.85755354 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.27115924 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.00081212 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99741077 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57399887 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32647417 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.21825310 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17288671 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.03942918 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83901385 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.65494979 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59723147 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58585774 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50183554 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45345835 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16404344 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84276642 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84270462 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80488408 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74428472 |
| 24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65982339 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64282392 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62302138 |
| 27 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60533257 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59964517 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57938264 |
| 30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54776720 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53826381 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52335661 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52274716 |
| 34 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50946450 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50408904 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49220552 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47282720 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.46660505 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46420768 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.43809473 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43495689 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43362925 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40789504 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36299036 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35945955 |
| 46 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35597109 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35311848 |
| 48 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.35063861 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33780029 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33622367 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32013287 |
| 52 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29347898 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24922452 |
| 54 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23016794 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22178486 |
| 56 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22064648 |
| 57 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21739253 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21120546 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16628664 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14314941 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.14298065 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13910685 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13303090 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13303090 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12890755 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10469204 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10453018 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06912834 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04722941 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04509656 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04272209 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.04118860 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02990819 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02546251 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01035717 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00871793 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00371785 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99845365 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99096498 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97690841 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96748574 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92240308 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91788417 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90685012 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90681520 |
| 86 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90234362 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89697846 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88994483 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88960340 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87041068 |
| 91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.85764593 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84897132 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83669126 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83173316 |
| 95 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82569588 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81866012 |
| 97 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81499549 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 0.81302349 |
| 99 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81132737 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80649367 |
| 101 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80360235 |
| 102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80103315 |
| 103 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.79175821 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79031631 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78789641 |
| 106 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78486629 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78437776 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78100620 |
| 109 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.77297061 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76589450 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76032364 |
| 112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.75822243 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75641380 |
| 114 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.75534950 |
| 115 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.74868080 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 0.74711534 |
| 117 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.72447710 |
| 118 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72419320 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71358017 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71358017 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70363917 |
| 122 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.70073212 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69790015 |
| 124 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.69619602 |
| 125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.69069798 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68865254 |
| 127 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.68045102 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67703872 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67313576 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67040974 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.66942384 |
| 132 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.66659811 |
| 133 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66415216 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66380578 |
| 135 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.65791270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.96710270 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.22867778 |
| 3 | MP0009785_altered_susceptibility_to | 4.05690871 |
| 4 | MP0003436_decreased_susceptibility_to | 3.66925243 |
| 5 | MP0003724_increased_susceptibility_to | 3.60201976 |
| 6 | MP0005671_abnormal_response_to | 3.37236541 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.09448903 |
| 8 | MP0000685_abnormal_immune_system | 3.09227517 |
| 9 | * MP0002419_abnormal_innate_immunity | 3.09183008 |
| 10 | MP0001790_abnormal_immune_system | 3.00166780 |
| 11 | MP0005387_immune_system_phenotype | 3.00166780 |
| 12 | * MP0005025_abnormal_response_to | 2.93330585 |
| 13 | MP0006082_CNS_inflammation | 2.70200444 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.58973323 |
| 15 | * MP0002723_abnormal_immune_serum | 2.50185924 |
| 16 | MP0001800_abnormal_humoral_immune | 2.44503686 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.32450147 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.26065342 |
| 19 | * MP0001819_abnormal_immune_cell | 2.19680409 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.15159609 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.09007037 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.08941694 |
| 23 | MP0001853_heart_inflammation | 2.05901883 |
| 24 | MP0009764_decreased_sensitivity_to | 2.03763401 |
| 25 | MP0002006_tumorigenesis | 1.82397958 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.81284341 |
| 27 | * MP0001845_abnormal_inflammatory_respons | 1.80476490 |
| 28 | MP0005310_abnormal_salivary_gland | 1.77040886 |
| 29 | MP0002405_respiratory_system_inflammati | 1.75691172 |
| 30 | MP0000604_amyloidosis | 1.73810931 |
| 31 | MP0008004_abnormal_stomach_pH | 1.70393720 |
| 32 | MP0004947_skin_inflammation | 1.64202689 |
| 33 | MP0008469_abnormal_protein_level | 1.64174200 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.60764506 |
| 35 | MP0004510_myositis | 1.58136525 |
| 36 | MP0003303_peritoneal_inflammation | 1.54759168 |
| 37 | * MP0000716_abnormal_immune_system | 1.54363976 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.52516372 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.49101405 |
| 40 | MP0005451_abnormal_body_composition | 1.44654380 |
| 41 | MP0003690_abnormal_glial_cell | 1.41791729 |
| 42 | MP0003186_abnormal_redox_activity | 1.40267596 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.39131858 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.37649917 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.37147763 |
| 46 | * MP0002398_abnormal_bone_marrow | 1.37003040 |
| 47 | MP0003448_altered_tumor_morphology | 1.35341249 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.33985269 |
| 49 | MP0000343_altered_response_to | 1.31040528 |
| 50 | MP0002254_reproductive_system_inflammat | 1.30164067 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.29018382 |
| 52 | MP0001879_abnormal_lymphatic_vessel | 1.28157699 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.23617420 |
| 54 | * MP0002429_abnormal_blood_cell | 1.22793522 |
| 55 | MP0005171_absent_coat_pigmentation | 1.20451768 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.18836696 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.18836696 |
| 58 | MP0003075_altered_response_to | 1.17608462 |
| 59 | MP0002163_abnormal_gland_morphology | 1.17200462 |
| 60 | MP0005390_skeleton_phenotype | 1.16280914 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.15324083 |
| 62 | MP0004883_abnormal_blood_vessel | 1.13598181 |
| 63 | MP0000858_altered_metastatic_potential | 1.13294936 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.11765721 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.08164294 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.07851418 |
| 67 | MP0002722_abnormal_immune_system | 1.07808817 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.98922049 |
| 69 | MP0005164_abnormal_response_to | 0.97557148 |
| 70 | MP0002933_joint_inflammation | 0.97107202 |
| 71 | MP0000920_abnormal_myelination | 0.96610274 |
| 72 | MP0008260_abnormal_autophagy | 0.95459039 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.94411523 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.92656024 |
| 75 | MP0001851_eye_inflammation | 0.92475829 |
| 76 | MP0006054_spinal_hemorrhage | 0.91922337 |
| 77 | MP0005379_endocrine/exocrine_gland_phen | 0.91753623 |
| 78 | MP0009697_abnormal_copulation | 0.90503938 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.89840515 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.89266715 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.87410407 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.87072606 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.87059368 |
| 84 | MP0005166_decreased_susceptibility_to | 0.85682898 |
| 85 | MP0001663_abnormal_digestive_system | 0.84997085 |
| 86 | MP0001542_abnormal_bone_strength | 0.84716655 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.84121065 |
| 88 | MP0003828_pulmonary_edema | 0.82320471 |
| 89 | MP0003795_abnormal_bone_structure | 0.81351732 |
| 90 | MP0005165_increased_susceptibility_to | 0.80897374 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.80249772 |
| 92 | MP0009763_increased_sensitivity_to | 0.79598734 |
| 93 | MP0000371_diluted_coat_color | 0.77907041 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.77128201 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.74428115 |
| 96 | MP0003866_abnormal_defecation | 0.72812455 |
| 97 | MP0009840_abnormal_foam_cell | 0.71758301 |
| 98 | MP0001881_abnormal_mammary_gland | 0.71231706 |
| 99 | MP0005408_hypopigmentation | 0.70782762 |
| 100 | MP0003136_yellow_coat_color | 0.69425510 |
| 101 | MP0003195_calcinosis | 0.69139289 |
| 102 | MP0004381_abnormal_hair_follicle | 0.68061479 |
| 103 | MP0002396_abnormal_hematopoietic_system | 0.67909123 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.67548181 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.67162061 |
| 106 | MP0002132_abnormal_respiratory_system | 0.66868966 |
| 107 | MP0003279_aneurysm | 0.66388089 |
| 108 | MP0001873_stomach_inflammation | 0.66294000 |
| 109 | MP0000372_irregular_coat_pigmentation | 0.65540050 |
| 110 | MP0000249_abnormal_blood_vessel | 0.65149199 |
| 111 | MP0003091_abnormal_cell_migration | 0.65007500 |
| 112 | MP0009278_abnormal_bone_marrow | 0.64947940 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.63388940 |
| 114 | MP0003941_abnormal_skin_development | 0.62457335 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.61268550 |
| 116 | MP0000490_abnormal_crypts_of | 0.61222699 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.61191208 |
| 118 | MP0003329_amyloid_beta_deposits | 0.60791368 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.60112950 |
| 120 | MP0008874_decreased_physiological_sensi | 0.58345244 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.58052840 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.57191597 |
| 123 | MP0005023_abnormal_wound_healing | 0.52914619 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52863246 |
| 125 | MP0000609_abnormal_liver_physiology | 0.51994978 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.51245240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.27457860 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.90639789 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.89756316 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.69328482 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.41378746 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.10833914 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01628674 |
| 8 | Myositis (HP:0100614) | 3.99673244 |
| 9 | Loss of speech (HP:0002371) | 3.96351487 |
| 10 | Prostate neoplasm (HP:0100787) | 3.87052991 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.86562726 |
| 12 | Basal ganglia calcification (HP:0002135) | 3.82231461 |
| 13 | Increased IgM level (HP:0003496) | 3.81307796 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.80450056 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.67850213 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.67201426 |
| 17 | Parakeratosis (HP:0001036) | 3.65967164 |
| 18 | Recurrent skin infections (HP:0001581) | 3.63447817 |
| 19 | Optic neuritis (HP:0100653) | 3.62741688 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.62741688 |
| 21 | Orchitis (HP:0100796) | 3.59723394 |
| 22 | Vasculitis (HP:0002633) | 3.50944437 |
| 23 | Chronic otitis media (HP:0000389) | 3.39509566 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.30175498 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.30034866 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20645336 |
| 27 | Obstructive lung disease (HP:0006536) | 3.20645336 |
| 28 | Mutism (HP:0002300) | 3.09067654 |
| 29 | Gingivitis (HP:0000230) | 3.07722049 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07334658 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07334658 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07334658 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.00876801 |
| 34 | Poor head control (HP:0002421) | 2.98274648 |
| 35 | Pustule (HP:0200039) | 2.95472922 |
| 36 | Amyloidosis (HP:0011034) | 2.94331101 |
| 37 | Petechiae (HP:0000967) | 2.92605341 |
| 38 | Axonal loss (HP:0003447) | 2.91352834 |
| 39 | Stomatitis (HP:0010280) | 2.91040505 |
| 40 | Recurrent pneumonia (HP:0006532) | 2.90336197 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90176733 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.90176733 |
| 43 | Periodontitis (HP:0000704) | 2.86812507 |
| 44 | Cheilitis (HP:0100825) | 2.86297277 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.82805531 |
| 46 | Hypergammaglobulinemia (HP:0010702) | 2.74412865 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73612006 |
| 48 | Recurrent viral infections (HP:0004429) | 2.66908429 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.66351177 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.64357262 |
| 51 | Cellulitis (HP:0100658) | 2.61353593 |
| 52 | Urticaria (HP:0001025) | 2.60426415 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.58588786 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.57325260 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.56746305 |
| 56 | Tetraparesis (HP:0002273) | 2.55232901 |
| 57 | T lymphocytopenia (HP:0005403) | 2.53299685 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.51652883 |
| 59 | Meningitis (HP:0001287) | 2.50680751 |
| 60 | Myocardial infarction (HP:0001658) | 2.49923438 |
| 61 | Nuclear cataract (HP:0100018) | 2.47362556 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.47084003 |
| 63 | Increased serum ferritin (HP:0003281) | 2.45087677 |
| 64 | Encephalitis (HP:0002383) | 2.44972430 |
| 65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44134076 |
| 66 | Thick nail (HP:0001805) | 2.42576328 |
| 67 | Progressive neurologic deterioration (HP:0002344) | 2.35958446 |
| 68 | Hematochezia (HP:0002573) | 2.35925373 |
| 69 | Alopecia of scalp (HP:0002293) | 2.34882832 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34237914 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33090249 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33090249 |
| 73 | Progressive visual loss (HP:0000529) | 2.31020748 |
| 74 | Polyneuropathy (HP:0001271) | 2.27938923 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.27720531 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.27720531 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.27720531 |
| 78 | Eosinophilia (HP:0001880) | 2.27113787 |
| 79 | Purpura (HP:0000979) | 2.26031926 |
| 80 | Pulmonary embolism (HP:0002204) | 2.22847276 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 2.21602676 |
| 82 | Hemoptysis (HP:0002105) | 2.21157510 |
| 83 | Inappropriate behavior (HP:0000719) | 2.17757906 |
| 84 | Thrombocytosis (HP:0001894) | 2.15640122 |
| 85 | Abnormality of the pleura (HP:0002103) | 2.12370354 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.10261232 |
| 87 | Osteomyelitis (HP:0002754) | 2.08910286 |
| 88 | Arterial thrombosis (HP:0004420) | 2.08744359 |
| 89 | Chest pain (HP:0100749) | 2.08479431 |
| 90 | Gingival bleeding (HP:0000225) | 2.08280213 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.08029804 |
| 92 | Joint swelling (HP:0001386) | 2.07351348 |
| 93 | Disinhibition (HP:0000734) | 2.06957240 |
| 94 | Episodic fever (HP:0001954) | 2.06294667 |
| 95 | Glomerulopathy (HP:0100820) | 2.06096868 |
| 96 | Apathy (HP:0000741) | 2.05873721 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.05802204 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.05671599 |
| 99 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.05202318 |
| 100 | Diminished motivation (HP:0000745) | 2.04896271 |
| 101 | Leukocytosis (HP:0001974) | 2.04448957 |
| 102 | Glomerulonephritis (HP:0000099) | 2.03368631 |
| 103 | Gangrene (HP:0100758) | 2.03350403 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.02899218 |
| 105 | Complement deficiency (HP:0004431) | 2.02217460 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.02104389 |
| 107 | Restrictive lung disease (HP:0002091) | 2.01656002 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.01410905 |
| 109 | Anorexia (HP:0002039) | 2.01101866 |
| 110 | Autoimmune hemolytic anemia (HP:0001890) | 2.01004029 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 2.00902370 |
| 112 | Epistaxis (HP:0000421) | 2.00597527 |
| 113 | IgG deficiency (HP:0004315) | 2.00483505 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.99515673 |
| 115 | Bone pain (HP:0002653) | 1.98499984 |
| 116 | Agnosia (HP:0010524) | 1.97399849 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.97002433 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.96552433 |
| 119 | Erythema (HP:0010783) | 1.94850068 |
| 120 | Hyperphosphatemia (HP:0002905) | 1.94792476 |
| 121 | Skin ulcer (HP:0200042) | 1.94697042 |
| 122 | Arthralgia (HP:0002829) | 1.93831069 |
| 123 | Increased IgE level (HP:0003212) | 1.93179908 |
| 124 | Abnormality of complement system (HP:0005339) | 1.91236882 |
| 125 | Pathologic fracture (HP:0002756) | 1.90224825 |
| 126 | IgM deficiency (HP:0002850) | 1.88056911 |
| 127 | Erythroderma (HP:0001019) | 1.87949321 |
| 128 | Abnormality of dental color (HP:0011073) | 1.87169926 |
| 129 | Conjunctival telangiectasia (HP:0000524) | 1.86852454 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86381245 |
| 131 | Memory impairment (HP:0002354) | 1.86372262 |
| 132 | Vertigo (HP:0002321) | 1.86291311 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.85695314 |
| 134 | Peritonitis (HP:0002586) | 1.85670778 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.85340583 |
| 136 | Abnormality of eosinophils (HP:0001879) | 1.84837140 |
| 137 | Granulocytopenia (HP:0001913) | 1.84426267 |
| 138 | Patchy hypopigmentation of hair (HP:0011365) | 1.82797635 |
| 139 | IgA deficiency (HP:0002720) | 1.82562233 |
| 140 | Osteolytic defects of the hand bones (HP:0009699) | 1.80616430 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80616430 |
| 142 | Joint hemorrhage (HP:0005261) | 1.80240160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.09508960 |
| 2 | RIPK4 | 3.77760583 |
| 3 | PBK | 3.42216480 |
| 4 | BLK | 3.09943437 |
| 5 | IRAK3 | 2.86750296 |
| 6 | SIK3 | 2.75388714 |
| 7 | TBK1 | 2.73490963 |
| 8 | TYK2 | 2.59271623 |
| 9 | JAK3 | 2.55180921 |
| 10 | PIM2 | 2.47034961 |
| 11 | IRAK4 | 2.40187562 |
| 12 | BMPR1B | 2.39216276 |
| 13 | MAP2K3 | 2.29204448 |
| 14 | IKBKB | 2.27508361 |
| 15 | TXK | 2.24296497 |
| 16 | NME2 | 2.09911524 |
| 17 | MAP3K3 | 2.06585086 |
| 18 | IKBKE | 2.05688979 |
| 19 | ACVR1B | 1.99917408 |
| 20 | FGR | 1.95669883 |
| 21 | KIT | 1.81085727 |
| 22 | TAOK2 | 1.80943446 |
| 23 | MAP4K1 | 1.80866915 |
| 24 | TEC | 1.78061094 |
| 25 | MST4 | 1.71410261 |
| 26 | FES | 1.70821302 |
| 27 | BMPR2 | 1.69969261 |
| 28 | ADRBK2 | 1.61057899 |
| 29 | MAP3K11 | 1.57765560 |
| 30 | JAK1 | 1.55835022 |
| 31 | ERN1 | 1.51579539 |
| 32 | PRPF4B | 1.50621070 |
| 33 | DDR2 | 1.41535819 |
| 34 | TAOK1 | 1.39349133 |
| 35 | MARK3 | 1.36966849 |
| 36 | KDR | 1.32581269 |
| 37 | SYK | 1.27158253 |
| 38 | NEK9 | 1.23084948 |
| 39 | CHUK | 1.22736465 |
| 40 | EIF2AK1 | 1.22065410 |
| 41 | EIF2AK2 | 1.21821475 |
| 42 | BTK | 1.18842428 |
| 43 | EIF2AK3 | 1.17957880 |
| 44 | CAMKK2 | 1.16550958 |
| 45 | TGFBR1 | 1.15217937 |
| 46 | RPS6KA4 | 1.14300066 |
| 47 | CSF1R | 1.14149562 |
| 48 | ARAF | 1.13727726 |
| 49 | MAP3K12 | 1.13013301 |
| 50 | EPHA3 | 1.11982526 |
| 51 | YES1 | 1.09023130 |
| 52 | ERBB3 | 1.08245048 |
| 53 | TRPM7 | 1.06934706 |
| 54 | MST1R | 1.06396964 |
| 55 | MAP3K1 | 1.06081507 |
| 56 | MAP3K13 | 1.06058974 |
| 57 | * LYN | 1.04666720 |
| 58 | TAOK3 | 1.04530848 |
| 59 | PIM1 | 1.00148023 |
| 60 | ZAP70 | 0.98852961 |
| 61 | CSK | 0.98188013 |
| 62 | TGFBR2 | 0.97369189 |
| 63 | GRK6 | 0.96067095 |
| 64 | NLK | 0.89644262 |
| 65 | CDC42BPA | 0.85955102 |
| 66 | LCK | 0.85322205 |
| 67 | FLT3 | 0.85015848 |
| 68 | HCK | 0.84962389 |
| 69 | RIPK1 | 0.80885622 |
| 70 | ZAK | 0.80781525 |
| 71 | INSRR | 0.80655566 |
| 72 | STK24 | 0.80576718 |
| 73 | ABL2 | 0.77706413 |
| 74 | NUAK1 | 0.76601928 |
| 75 | EPHB1 | 0.71520578 |
| 76 | MAP3K2 | 0.70286986 |
| 77 | TNK2 | 0.70107242 |
| 78 | SIK1 | 0.69824908 |
| 79 | MATK | 0.69371074 |
| 80 | STK3 | 0.68489797 |
| 81 | PRKCD | 0.68206330 |
| 82 | CDK19 | 0.67747582 |
| 83 | STK10 | 0.67243036 |
| 84 | IRAK1 | 0.66960374 |
| 85 | MAP2K6 | 0.66075181 |
| 86 | JAK2 | 0.64841262 |
| 87 | MUSK | 0.64616148 |
| 88 | GRK7 | 0.63821212 |
| 89 | TESK2 | 0.61191134 |
| 90 | PDK1 | 0.60772452 |
| 91 | STK4 | 0.60686622 |
| 92 | ABL1 | 0.60576997 |
| 93 | EPHA2 | 0.55491034 |
| 94 | VRK1 | 0.54887071 |
| 95 | PDPK1 | 0.54311939 |
| 96 | BCR | 0.53519911 |
| 97 | KSR2 | 0.52115264 |
| 98 | SIK2 | 0.51755656 |
| 99 | MAPK7 | 0.50204547 |
| 100 | PAK4 | 0.49606067 |
| 101 | NEK6 | 0.47713585 |
| 102 | TIE1 | 0.45711616 |
| 103 | FYN | 0.44910744 |
| 104 | ITK | 0.43335030 |
| 105 | MAP3K6 | 0.43333755 |
| 106 | CDK6 | 0.41871044 |
| 107 | DYRK3 | 0.40410700 |
| 108 | RPS6KL1 | 0.40343916 |
| 109 | RPS6KC1 | 0.40343916 |
| 110 | TESK1 | 0.40072621 |
| 111 | DAPK2 | 0.39920375 |
| 112 | BMX | 0.39748231 |
| 113 | FGFR4 | 0.39594315 |
| 114 | MAP3K5 | 0.39107233 |
| 115 | PDK2 | 0.39083523 |
| 116 | MAPKAPK2 | 0.38510647 |
| 117 | IGF1R | 0.37458636 |
| 118 | RPS6KA5 | 0.35781703 |
| 119 | FGFR3 | 0.35437727 |
| 120 | EGFR | 0.35357715 |
| 121 | PRKCE | 0.34084703 |
| 122 | CLK1 | 0.32794923 |
| 123 | MET | 0.32230446 |
| 124 | FRK | 0.31744949 |
| 125 | PIK3CG | 0.31289537 |
| 126 | CDK8 | 0.30695498 |
| 127 | BRAF | 0.30527535 |
| 128 | STK38L | 0.30465841 |
| 129 | MAPK4 | 0.30038067 |
| 130 | MAPK12 | 0.29764638 |
| 131 | MYLK | 0.28772452 |
| 132 | TNIK | 0.28679210 |
| 133 | PRKCQ | 0.26912830 |
| 134 | IRAK2 | 0.26008192 |
| 135 | DAPK3 | 0.25927528 |
| 136 | PRKG2 | 0.25497446 |
| 137 | INSR | 0.25226968 |
| 138 | MOS | 0.25024617 |
| 139 | LRRK2 | 0.24460455 |
| 140 | PTK2B | 0.24151668 |
| 141 | RPS6KA6 | 0.23899090 |
| 142 | ERBB4 | 0.23133736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.49235011 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46266817 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.17242379 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88922079 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.70405530 |
| 6 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67411951 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.58182981 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.48279638 |
| 9 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46523164 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.40395990 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.32753791 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.31658452 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27264731 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19638919 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13408596 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.11196796 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.91513364 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91177919 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.87403743 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.86374420 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86327202 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81625730 |
| 23 | * Pertussis_Homo sapiens_hsa05133 | 1.78873369 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75587708 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.73130015 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71701330 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63091813 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.61525735 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52578800 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.52559060 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52401962 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.49529768 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.39708492 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38790527 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33642338 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28743846 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.25416960 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17579755 |
| 39 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.16667181 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.13966109 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09261058 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.06436940 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03460205 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01499987 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99272396 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98081349 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97593990 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96676630 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88433393 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87104676 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.85063016 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.80642377 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80463221 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74355693 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66344992 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65841379 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65102918 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63926663 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62885040 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61587178 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.58990844 |
| 62 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56845767 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56757940 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54561386 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.54279182 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54220267 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53759145 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.53487228 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52956733 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.52136973 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51526861 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50447142 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48079697 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46616998 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45662805 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44534319 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.43099241 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42938415 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42306730 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41459794 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40964764 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36119211 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35974587 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35162235 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33095659 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32880296 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32441150 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32173978 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31270246 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30284203 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.30233789 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29679157 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.28592970 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.27966494 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27751871 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26023358 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.25294308 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23327744 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22512243 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20671668 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19362882 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.18864124 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18817116 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18641032 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.16831809 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16770710 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16452764 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.16189453 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.15358009 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15205889 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12705922 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12653058 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.11228174 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11201132 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10266423 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.08398372 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07539711 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07464319 |

